http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101009714-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2008-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101009714-B1 |
| titleOfInvention | Pharmaceutical composition for the prevention and treatment of inflammatory diseases comprising the bark of lacquer |
| abstract | The present invention is a bark ( Rhus) succedanea ) relates to an anti-inflammatory composition containing an immature fruit extract as an active ingredient, the bark lacquer extract of the present invention inhibits the production of nitrogen oxides (NO), inhibits the expression of inducible nitrogen oxide synthase (iNOS) and pre- It has anti-inflammatory effect and no cytotoxicity through inhibiting and inhibiting expression of interleukin-1β (IL-1β), an inflammatory cytokine, and thus is useful for medicines, dietary supplements or functional foods for the prevention and treatment of inflammatory diseases. Can be used.n n n n Immature bark, anti-inflammatory, nitrogen oxide, nitrogen oxide synthase, interleukin-1β |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102217470-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200092186-A |
| priorityDate | 2008-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.